Pacer Advisors, Inc. Amgen Inc Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 67,343 shares of AMGN stock, worth $19.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

67,343

Previous 74,039 9.04%

Holding current value

$19.4 Million

Previous $23.1 Million 6.2%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $2.07 Million - $2.26 Million	-6,696 Reduced 9.04%	67,343 $21.7 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $1.59 Million - $1.93 Million	6,048 Added 8.9%	74,039 $23.1 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $1.49 Million - $1.79 Million	-5,524 Reduced 7.51%	67,991 $19.3 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $31.7 Million - $35.8 Million	-124,123 Reduced 62.8%	73,515 $21.2 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $3.93 Million - $4.88 Million	17,991 Added 10.01%	197,638 $53.1 Million
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $23.6 Million - $27.9 Million	110,226 Added 158.78%	179,647 $39.9 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $2.68 Million - $3.27 Million	11,885 Added 20.66%	69,421 $16.8 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $8.64 Million - $11 Million	37,730 Added 190.5%	57,536 $15.1 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $7.13 Million - $8.05 Million	-31,783 Reduced 61.61%	19,806 $4.46 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $292,309 - $325,289	-1,267 Reduced 2.4%	51,589 $12.6 Million
Q1 2022 Apr 05, 2022	SELL	$219.27 - $242.57 $1.57 Million - $1.73 Million	-7,150 Reduced 11.92%	52,856 $12.8 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $631,444 - $722,630	-3,175 Reduced 5.03%	60,006 $13.5 Million
Q3 2021 Oct 15, 2021	SELL	$212.27 - $248.7 $34,175 - $40,040	-161 Reduced 0.25%	63,181 $13.4 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $2.88 Million - $3.19 Million	12,322 Added 24.15%	63,342 $15.4 Million
Q1 2021 Apr 05, 2021	SELL	$221.91 - $258.6 $796,656 - $928,374	-3,590 Reduced 6.57%	51,020 $12.7 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $6.54 Million - $7.79 Million	-30,240 Reduced 35.64%	54,610 $12.6 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $3.02 Million - $3.36 Million	-12,869 Reduced 13.17%	84,850 $21.6 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $9.79 Million - $12 Million	49,502 Added 102.67%	97,719 $23 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $256,958 - $340,797	1,410 Added 3.01%	48,217 $11.3 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $15.7 Million - $20.2 Million	-82,858 Reduced 63.9%	46,807 $11.3 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $371,898 - $445,612	2,136 Added 1.67%	129,665 $25.1 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $1.86 Million - $2.18 Million	11,134 Added 9.57%	127,529 $23.5 Million
Q1 2019 Apr 10, 2019	BUY	$180.87 - $203.88 $17.8 Million - $20.1 Million	98,479 Added 549.67%	116,395 $22.1 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $10.5 Million - $12.2 Million	-58,586 Reduced 76.58%	17,916 $3.49 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $3.59 Million - $4.05 Million	19,366 Added 33.89%	76,502 $15.9 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1.61 Million - $1.8 Million	9,666 Added 20.36%	57,136 $10.5 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $1.06 Million - $1.24 Million	6,245 Added 15.15%	47,470 $8.09 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $2.14 Million - $2.39 Million	12,660 Added 44.32%	41,225 $7.17 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $4.78 Million - $5.46 Million	28,565	28,565 $5.33 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Amgen Inc Transaction History